The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain.
Open Access
- 1 April 1991
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 87 (4) , 1227-1233
- https://doi.org/10.1172/jci115123
Abstract
Type IIB von Willebrand Disease (vWD) is characterized by the selective loss of large von Willebrand Factor (vWF) multimers from plasma, presumably due to their increased reactivity with platelets and subsequent clearance from the circulation. Using the PCR, one of a panel of four potential missense mutations was identified in each of the 14 patients studied from 11 unrelated families. None of these substitutions was encountered in a large panel of normal DNAs. These changes all represent C----T transitions at CpG dinucleotides, proposed "hot spots" for mutation in the human genome. The four resulting amino acid substitutions, Arg543----Trp, Arg545----Cys, Val553----Met, and Arg578----Gln, are all clustered within the GpIb binding domain of vWF. Disruption of this latter functional domain may explain the pathogenesis of Type IIB vWD. By sequence polymorphism analysis, the Arg543----Trp substitution was shown to have occurred as at least two independent mutational events. This latter observation, along with the identification of mutations in all 14 patients studied and their localization to the GpIb binding domain, all strongly suggest that these substitutions represent the authentic defects responsible for Type IIB vWD. This panel of mutations may provide a useful diagnostic tool for the majority of patients with Type IIB vWD.Keywords
This publication has 37 references indexed in Scilit:
- USE OF POLYMERASE CHAIN REACTION-DETECTED SEQUENCE POLYMORPHISMS TO DOCUMENT ENGRAFTMENT FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1990
- Postoperative thrombocytopenia in type IIB von Willebrand diseaseAmerican Journal of Hematology, 1990
- Spontaneous platelet aggregation in type IIB tampa von willebrand disease is inhibited by the 52/48-kDa fragment of normal von willebrand factor, which contains the GPIb binding domainAmerican Journal of Hematology, 1989
- The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.Journal of Clinical Investigation, 1988
- Investigation of a large kindred with type IIB von Willebrand's disease, dominant inheritance and age-dependent thrombocytopeniaBritish Journal of Haematology, 1988
- Identification of disulfide-bridged substructures within human von Willebrand factorBiochemistry, 1987
- Structure of pre-pro-von Willebrand factor and its expression in heterologous cellsNature, 1986
- Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.Journal of Clinical Investigation, 1985
- Platelet Aggregation Induced by I-Desamino-8-D-Arginine Vasopressin (dDAVP) in Type IIb von Willebrand's DiseaseNew England Journal of Medicine, 1983
- Heightened Interaction between Platelets and Factor VIII/von Willebrand Factor in a New Subtype of von Willebrand's DiseaseNew England Journal of Medicine, 1980